← Latest papers
🧬 biology

Distinctive properties of the prion protein in the brain and retina in the amyloidosis associated with the PRNP F198S Mutation. *

This study provides the first comparative neuropathologic and biochemical analysis of PrP deposits in the brain and retina of individuals with GSS-associated F198S mutation, revealing that while both tissues contain seeding-capable aggregates, the retina lacks the constitutive 8 kDa proteolytic fragments found in the brain and exhibits distinct amyloid and glycosylation properties.

Original authors: Bernardino Ghetti, Bradley S. Glazier, Michele Fiorini, Kathy L. Newell, José M. Bonnin, Jill R. Murrell, Leah Rie Varner, Max Jacobsen, James F. Striebel, Suzette A. Priola, Gianluigi Zanusso

Published 2026-07-16
📖 6 min read🧠 Deep dive

Original authors: Bernardino Ghetti, Bradley S. Glazier, Michele Fiorini, Kathy L. Newell, José M. Bonnin, Jill R. Murrell, Leah Rie Varner, Max Jacobsen, James F. Striebel, Suzette A. Priola, Gianluigi Zanusso

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Imagine your brain is a bustling city, and inside every building, there are tiny, essential workers called proteins. These workers keep the city running, but sometimes, due to a glitch in their instruction manual (a gene mutation), they get confused. Instead of doing their jobs, they fold into the wrong shape, stick together, and form sticky, useless clumps. This is the story of prion diseases, a rare and scary group of conditions where these misfolded proteins spread like a bad rumor, turning healthy tissue into a sponge full of holes. One specific type of this disease, called Gerstmann-Sträussler-Scheinker (GSS), is caused by a tiny typo in the genetic code at position 198.

Scientists have long known that this sticky mess happens in the brain, causing memory loss and movement problems. But the eye is actually part of the brain, wrapped up in a little package at the front of your face. It's like a window into the city. If the city is having a protein crisis, shouldn't the window show the same mess? That's the big question. Researchers wanted to know if the "sticky clumps" in the eye looked exactly like the ones in the brain, or if the eye had its own unique way of handling this disaster. Understanding this could help us see if the eye can be used as an early warning system for these diseases, or if the eye and brain are fighting the problem in completely different ways.


The Tale of Two Cities: Brain vs. Eye

In this study, a team of scientists from Indiana University and the National Institutes of Health decided to take a closer look at the "sticky clumps" in both the brain and the eyes of people who had passed away from a specific type of GSS caused by the F198S mutation. They treated the brain and the retina (the light-sensitive layer at the back of the eye) like two different neighborhoods in the same city to see how the protein disaster played out in each.

The Brain: A City Full of Sticky Cores
In the brains of these patients, the story was exactly what scientists expected. The misfolded proteins gathered into massive, hard-to-break clumps called plaques. If you looked at these plaques under a special light, they glowed like neon signs. This glow happens because the proteins had formed a rigid, crystal-like structure called "amyloid." Inside these glowing cores, the proteins had been chopped up by the body's natural cleanup crew into tiny, 8-kilodalton (kDa) fragments. These fragments were the building blocks of the amyloid, and they were everywhere, acting like the concrete foundation of a bad building.

The Eye: A Quiet Neighborhood with Beads, Not Cores
But when the scientists looked at the retina, the story changed completely. Instead of the giant, glowing neon plaques seen in the brain, the eye had something much stranger: tiny, bead-like clusters of protein. These beads were found only in one specific layer of the retina called the outer plexiform layer (OPL), which is where the eye's light-sensing cells talk to the next layer of cells.

Here is the twist: These beads did not glow. When the scientists shone their special light on them, they stayed dark. This meant they were not amyloid. They didn't have that rigid, crystal-like structure. Furthermore, when they tried to find the tiny 8 kDa fragments that were the signature of the brain's amyloid, they couldn't find them in the eye. The eye's beads were made of full-length proteins, not the chopped-up pieces.

The "Seeding" Test: Who is the Better Spreader?
To see how contagious these protein clumps were, the researchers used a test called RT-QuIC. Imagine this test as a "snowball fight." You take a tiny bit of the protein clump and throw it into a bucket of healthy proteins. If the clump is a good "seed," it will make the healthy proteins fold wrong and join the fight, creating a massive snowball avalanche.

The results showed a clear difference in "snowball power." The brain clumps were fierce fighters; even when the scientists diluted the brain sample a million times (10⁻⁶), the snowball fight still started. However, the eye beads were much weaker. They could only start a fight if the sample was diluted a hundred times (10⁻²). By the time they tried to dilute it a million times, the eye beads gave up and did nothing. This suggests that the protein clumps in the eye are much less "contagious" or "seeding" than the ones in the brain.

The Mystery of the Missing Scissors
One of the most fascinating discoveries was about how the proteins got chopped up. In the brain, the body naturally has a pair of "scissors" (an enzyme) that cuts the protein into those tiny 8 kDa fragments, which then build the amyloid cores. The eye, however, seemed to lack these scissors. The 8 kDa fragments were completely missing from the eye's natural state.

But here's the kicker: when the scientists took the eye tissue into the lab and forced it to be cut with a chemical "scissors" (Proteinase K), the 8 kDa fragments suddenly appeared. This suggests that the eye can make these fragments, but it just doesn't have the right tools to do it naturally. It's like a kitchen that has all the ingredients for a cake but is missing the oven; you can't bake the cake until you bring in an oven from the outside.

The Sugar Coating Difference
The scientists also noticed that the proteins in the eye were wearing a different "sugar coat" (glycosylation) than the ones in the brain. The eye proteins had a unique, complex sugar pattern that the brain proteins didn't have. This suggests that the environment of the eye changes the protein in a way that prevents it from turning into the hard, amyloid clumps seen in the brain.

What Does This Mean?
The study concludes that while the brain and the eye are both part of the central nervous system, they handle this protein disaster in very different ways. The brain turns the protein into hard, glowing, amyloid cores that are highly contagious. The eye, however, keeps the protein in a softer, non-amyloid, bead-like form that is less contagious and lacks the specific chopped-up fragments found in the brain.

The authors suggest that this difference might be because the eye and brain have different "cleanup crews" or different chemical environments. They also note that while the eye has these beads, we don't yet know if they cause vision problems or if the eye is just a passive bystander. The study opens the door to asking whether we can look at the eye to understand how the brain is doing, but for now, it tells us that the eye is not just a smaller version of the brain—it's a whole different neighborhood with its own rules.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →